Skip to main content
Gabriel India Ltd. logo

Gabriel India Ltd. — Investor Relations & Filings

Ticker · GABRIEL ISIN · INE524A01029 LEI · 335800N5IVWLLVVTL509 BSE.NS Manufacturing
Open in API
Filings indexed 1,328 across all filing types
Latest filing 2025-11-18 Regulatory Filings
Country IN India
Listing BSE.NS GABRIEL

About Gabriel India Ltd.

https://www.anandgroupindia.com/gabriel…

Gabriel India Ltd. specializes in the design and manufacture of ride control products, including shock absorbers, struts, front forks, and cabin dampers. The company provides high-performance suspension solutions across multiple segments, such as two-wheelers, three-wheelers, passenger cars, and commercial vehicles, in addition to specialized applications for the railway sector. As a key member of the Anand Group, it maintains strong partnerships with major original equipment manufacturers (OEMs) and operates an extensive aftermarket distribution network. The organization is characterized by its focus on research and development, engineering innovation, and the production of durable components designed to improve vehicle stability and passenger comfort. Its manufacturing operations utilize advanced technologies to meet rigorous quality standards for both domestic and global requirements.

Recent filings

Filing Released Lang Actions
Receipt of Observation Letter with No Objection from National Stock Exchange Limited (NSE)
Regulatory Filings Classification · 95% confidence The document is an official communication from Gabriel India Limited to stock exchanges regarding receipt of an observation letter with 'no objection' from the National Stock Exchange of India for a proposed Composite Scheme of Arrangement involving amalgamation and demerger. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements Regulations and the Companies Act, 2013. The document includes detailed conditions and observations from the stock exchange and SEBI about the scheme, but it is not the scheme document itself or a financial report. It is an announcement of regulatory approval and procedural steps to file the scheme with the National Company Law Tribunal (NCLT). The document is lengthy (15,000 characters) but primarily serves as a regulatory update and notification rather than a financial report or detailed scheme document. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance update related to the scheme filing process.
2025-11-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (1427 characters) informing the stock exchanges about the recording of a conference call related to the company's Q2 FY26 operational and financial performance. It provides a link to the audio recording but does not contain the transcript or detailed financial data itself. This is an announcement about the availability of a call recording, not the call transcript itself. According to the classification rules, announcements about conference calls or their recordings fall under Regulatory Filings (RNS) since it is a regulatory disclosure but not the full transcript or detailed report.
2025-11-13 English
Intimation under regulation 30 (LODR) - regarding Audio Transcript of Investor / Analyst Meet held on November 13, 2025.
Regulatory Filings Classification · 95% confidence The document is a short notice (1427 characters) informing the stock exchanges about the recording of a conference call related to the company's Q2 FY26 operational and financial performance. It provides a link to the audio recording but does not contain the transcript itself or detailed financial data. The document is an intimation under SEBI regulations about the availability of the conference call recording, not the call transcript itself. According to the rules, announcements about conference calls or their recordings are classified as Regulatory Filings (RNS) rather than Call Transcripts (CT), which require the full text transcript. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-11-13 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation November 2025' and is addressed as an Investors/Result presentation for the quarter and half year ended September 30, 2025. It contains detailed financial highlights, segment performance, strategic business drivers, and other operational data typical of an investor presentation. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. It explicitly states it is a presentation and includes forward-looking statements and detailed financial metrics. Therefore, it fits the category of an Investor Presentation (IP).
2025-11-12 English
Intimation under Regulation 30 (LODR) - regarding investor presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation November 2025' and is addressed as an Investors/Result presentation for the quarter and half year ended September 30, 2025. It contains detailed financial highlights, segment performance, strategic business drivers, and other operational data. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. The content includes financial metrics such as revenue, EBITDA, PBT, PAT, balance sheet data, cash flow, capex, and market share details, which are typical of investor presentations. There is no indication that this is an official annual or quarterly report filing, audit report, or earnings release. It is clearly a presentation prepared for investors to update them on recent financial results and business strategy. Therefore, the document fits the category of an Investor Presentation (IP).
2025-11-12 English
Intimation under regulation 30 (LODR) Regarding Agreements
Regulatory Filings Classification · 95% confidence The document is a disclosure filed by Gabriel India Limited regarding the outcome of a Board of Directors meeting held on November 12, 2025. It details approvals related to a revised Joint Venture Agreement, amended agreements, and investment agreements involving related parties. The document references compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosures of material events by listed companies in India. The content is an announcement of corporate actions and agreements approved by the board, not a full financial report or detailed management discussion. It is a regulatory announcement about corporate governance and material agreements rather than a financial report, earnings release, or management report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-11-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.